Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory from the American Heart Association

15Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Wearables allow patients to access their personal data and monitor their health. Despite substantial technologic advances in recent years, issues with hardware design, data analysis, and integration into the clinical workflow prevent wearables from reaching their potential in high-risk congenital heart disease populations. This science advisory reviews the use of wearables in patients with congenital heart disease, how to improve these technologies for clinicians and patients, and ethical and regulatory considerations. Challenges related to the use of wearables are common to every clinical setting, but specific topics for consideration in congenital heart disease are highlighted.

Cite

CITATION STYLE

APA

Tandon, A., Avari Silva, J. N., Bhatt, A. B., Drummond, C. K., Hill, A. C., Paluch, A. E., … Harris, K. C. (2024, May 7). Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory from the American Heart Association. Circulation. Lippincott Williams and Wilkins. https://doi.org/10.1161/CIR.0000000000001225

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free